BillyWu的个人主页 - 老虎社区

BillyWu

BillyWu

暂无个人介绍

IP属地：未知

337关注

25粉丝

0主题

0勋章

2021-12-17

Haiz.........

U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%

2021-11-11

$SoFi Technologies Inc.(SOFI)$ Rocket to the moon.

2021-12-17

Omg.

EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%

2021-11-12

$SoFi Technologies Inc.(SOFI)$ Rocket all the way.

2021-12-22

$American Virtual Cloud Technologies, Inc.(AVCT)$ Rocket to the moon later today.

2021-11-26

Great. Thanks.

5 Stocks To Watch For November 26, 2021

2021-12-22

Omg

Biogen shares fell 1.2% in early trading

2021-12-22

Great

BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody

2021-12-16

Great

Tesla Bags Top-Rated EV Badge From Edmunds, Rivian Gets Editor's Choice Crown

2021-11-24

$Lucid Group Inc(LCID)$ up up to the moon.

2021-11-13

$Gores Guggenheim Inc(GGPI)$ Rocketing very soon.

2021-12-16

Great

Stocks Set to Extend Gains Ahead of More Central Bank Decisions

2021-12-16

Wow.....

46 Biggest Movers From Yesterday

2021-12-15

$SoFi Technologies Inc.(SOFI)$ What happened to u SoFi darling? Are u sick? Lol.

2021-11-30

$iSpecimen Inc.(ISPC)$ up up rocket to the moon.

2021-11-18

$Gores Guggenheim Inc(GGPI)$ all the way

2021-11-15

Great.

Burger King parent to buy Firehouse Subs for $1 billion

2021-12-22

Omg

France cancels order for Merck's COVID-19 antiviral drug

2021-12-22

Great

GameStop Stock Set to Level Up With Adoption of Dogecoin and Shiba Inu Cryptos

2021-12-13

$SoFi Technologies Inc.(SOFI)$ what happened to my darling SoFi. Down so fast but up so slow. Lol.

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3587089033625952,"uuid":"3587089033625952","gmtCreate":1623995009001,"gmtModify":1625366527941,"name":"BillyWu","pinyin":"billywu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":337,"tweetSize":106,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.01","exceedPercentage":"80.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":639971577,"gmtCreate":1643151126322,"gmtModify":1643151126667,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Wake up AVCT.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Wake up AVCT.&nbsp;","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$ Wake up AVCT.","images":[{"img":"https://static.tigerbbs.com/62035a6e167a44401164842bc5619d11","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639971577","isVote":1,"tweetType":1,"viewCount":933,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630752737,"gmtCreate":1643064098986,"gmtModify":1643074778505,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Wake up SoFi.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Wake up SoFi.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ Wake up SoFi.","images":[{"img":"https://static.tigerbbs.com/59baf04d7667a686afb375ebfd80a3bc","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630752737","isVote":1,"tweetType":1,"viewCount":778,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630479756,"gmtCreate":1643033263399,"gmtModify":1643033263695,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>shooting soon. Lol.&nbsp;","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>shooting soon. Lol.&nbsp;","text":"$iSpecimen Inc.(ISPC)$shooting soon. Lol.","images":[{"img":"https://static.tigerbbs.com/028a72273223420fdb1a6c75a18fe63c","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630479756","isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630245067,"gmtCreate":1642941917321,"gmtModify":1642941917683,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;What happened to u ISpecimen?&nbsp;","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;What happened to u ISpecimen?&nbsp;","text":"$iSpecimen Inc.(ISPC)$ What happened to u ISpecimen?","images":[{"img":"https://static.tigerbbs.com/fda54aaa128c78601133b65dec1c1214","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630245067","isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630312029,"gmtCreate":1642693486469,"gmtModify":1642693486761,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PIXY\">$Shiftpixy Inc.(PIXY)$</a>What have shorters done to this stock? Haiz.....","listText":"<a href=\"https://laohu8.com/S/PIXY\">$Shiftpixy Inc.(PIXY)$</a>What have shorters done to this stock? Haiz.....","text":"$Shiftpixy Inc.(PIXY)$What have shorters done to this stock? Haiz.....","images":[{"img":"https://static.tigerbbs.com/f1c5fb6caee0784a658e66f3752b0142","width":"1080","height":"2431"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630312029","isVote":1,"tweetType":1,"viewCount":1112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":630316637,"gmtCreate":1642693296851,"gmtModify":1642693297190,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great. Rocket to the moon.&nbsp;","listText":"Great. Rocket to the moon.&nbsp;","text":"Great. Rocket to the moon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630316637","repostId":"1193796878","repostType":2,"repost":{"id":"1193796878","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642691541,"share":"https://www.laohu8.com/m/news/1193796878?lang=&edition=full","pubTime":"2022-01-20 23:12","market":"us","language":"en","title":"Fintech Stocks Jumped in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1193796878","media":"Tiger Newspress","summary":"Fintech stocks jumped in morning trading.SoFi Technologies, Paysafe, Affirm Holdings, Upstart Holdin","content":"<html><head></head><body><p>Fintech stocks jumped in morning trading.SoFi Technologies, Paysafe, Affirm Holdings, Upstart Holdings, Lemonade, Coinbase, LendingClub, Square, Mastercard and Visa climbed between 1% and 11%.</p><p><img src=\"https://static.tigerbbs.com/2881c0f1df17fe1ea0085add54b0243f\" tg-width=\"416\" tg-height=\"658\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fintech Stocks Jumped in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFintech Stocks Jumped in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-20 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Fintech stocks jumped in morning trading.SoFi Technologies, Paysafe, Affirm Holdings, Upstart Holdings, Lemonade, Coinbase, LendingClub, Square, Mastercard and Visa climbed between 1% and 11%.</p><p><img src=\"https://static.tigerbbs.com/2881c0f1df17fe1ea0085add54b0243f\" tg-width=\"416\" tg-height=\"658\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","AFRM":"Affirm Holdings, Inc.","PYPL":"PayPal","PSFE":"Paysafe Ltd","SOFI":"SoFi Technologies Inc.","UPST":"Upstart Holdings, Inc.","V":"Visa","SQ":"Block","COIN":"Coinbase Global, Inc.","LC":"LendingClub"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193796878","content_text":"Fintech stocks jumped in morning trading.SoFi Technologies, Paysafe, Affirm Holdings, Upstart Holdings, Lemonade, Coinbase, LendingClub, Square, Mastercard and Visa climbed between 1% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697784112,"gmtCreate":1642594614360,"gmtModify":1642594615579,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Rocket to the moon.&nbsp;","listText":"Rocket to the moon.&nbsp;","text":"Rocket to the moon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697784112","repostId":"1188286869","repostType":2,"repost":{"id":"1188286869","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642582881,"share":"https://www.laohu8.com/m/news/1188286869?lang=&edition=full","pubTime":"2022-01-19 17:01","market":"us","language":"en","title":"SoFi Stock Surged 19% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1188286869","media":"Tiger Newspress","summary":"SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged","content":"<html><head></head><body><p>SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.</p><p><img src=\"https://static.tigerbbs.com/ef762e6a723971ad235f0eb02c5bf06a\" tg-width=\"841\" tg-height=\"616\" width=\"100%\" height=\"auto\"/></p><p>The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.</p><p>“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.</p><p>SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.</p><p>“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.</p><p>The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.</p><p>The firm has also applied for approval as a bank holding company under Federal Reserve oversight.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoFi Stock Surged 19% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoFi Stock Surged 19% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-19 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.</p><p><img src=\"https://static.tigerbbs.com/ef762e6a723971ad235f0eb02c5bf06a\" tg-width=\"841\" tg-height=\"616\" width=\"100%\" height=\"auto\"/></p><p>The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.</p><p>“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.</p><p>SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.</p><p>“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.</p><p>The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.</p><p>The firm has also applied for approval as a bank holding company under Federal Reserve oversight.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188286869","content_text":"SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.The firm has also applied for approval as a bank holding company under Federal Reserve oversight.","news_type":1},"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697785409,"gmtCreate":1642594506477,"gmtModify":1642594508174,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Ahoot to the moon soon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Ahoot to the moon soon.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ Ahoot to the moon soon.","images":[{"img":"https://static.tigerbbs.com/48459660db06781463f7d5831ad88e30","width":"1080","height":"3608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697785409","isVote":1,"tweetType":1,"viewCount":493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":697785028,"gmtCreate":1642594381493,"gmtModify":1642594382677,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Fly to the moon.&nbsp;","listText":"Fly to the moon.&nbsp;","text":"Fly to the moon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697785028","repostId":"1188286869","repostType":2,"repost":{"id":"1188286869","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642582881,"share":"https://www.laohu8.com/m/news/1188286869?lang=&edition=full","pubTime":"2022-01-19 17:01","market":"us","language":"en","title":"SoFi Stock Surged 19% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1188286869","media":"Tiger Newspress","summary":"SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged","content":"<html><head></head><body><p>SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.</p><p><img src=\"https://static.tigerbbs.com/ef762e6a723971ad235f0eb02c5bf06a\" tg-width=\"841\" tg-height=\"616\" width=\"100%\" height=\"auto\"/></p><p>The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.</p><p>“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.</p><p>SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.</p><p>“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.</p><p>The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.</p><p>The firm has also applied for approval as a bank holding company under Federal Reserve oversight.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoFi Stock Surged 19% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoFi Stock Surged 19% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-19 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.</p><p><img src=\"https://static.tigerbbs.com/ef762e6a723971ad235f0eb02c5bf06a\" tg-width=\"841\" tg-height=\"616\" width=\"100%\" height=\"auto\"/></p><p>The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.</p><p>“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.</p><p>SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.</p><p>“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.</p><p>The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.</p><p>The firm has also applied for approval as a bank holding company under Federal Reserve oversight.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188286869","content_text":"SoFi Technologies Inc., the financial firm led by former Twitter Inc. executive Anthony Noto, surged 19% after the Office of the Comptroller of the Currency granted it a U.S. banking charter.The online lending platform acquired Golden Pacific Bank as a path to getting the full-fledged banking license, the regulator said in a statement on Tuesday. While the entity will have a national reach and SoFi’s well-established digital lending platform, the OCC said that the new license didn’t cover crypto transactions.“This incredible milestone elevates our ability to help even more people get their money right and realize their ambitions,” Noto, SoFi’s chief executive officer, said in a statement posted on the company’s website.SoFi was originally founded to set up affordable alternatives for student lending, and the rapidly growing company has since become one of the major financial technology firms, with millions of users through its online and mobile applications. A banking charter further cements its status in the U.S. financial system, and this long-expected development has been predicted by analysts to boost its earnings this year.“Today’s decision brings SoFi, a large fintech, inside the federal bank regulatory perimeter, where it will be subject to comprehensive supervision and the full panoply of bank regulations,” Michael Hsu, the acting chief of the OCC, said in a statement.The OCC said that in order to move past conditional status and become a full-service national bank, SoFi still needed to meet a number of the regulator’s requirements. The OCC said that the new license didn’t cover crypto transactions, unless specifically granted later by the agency.The firm has also applied for approval as a bank holding company under Federal Reserve oversight.","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697584051,"gmtCreate":1642518498487,"gmtModify":1642518498830,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BBIO\">$BridgeBio Pharma, Inc.(BBIO)$</a>&nbsp;What happened to SOFI? Faint.&nbsp;","listText":"<a href=\"https://laohu8.com/S/BBIO\">$BridgeBio Pharma, Inc.(BBIO)$</a>&nbsp;What happened to SOFI? Faint.&nbsp;","text":"$BridgeBio Pharma, Inc.(BBIO)$ What happened to SOFI? Faint.","images":[{"img":"https://static.tigerbbs.com/921e4645b0d5f30eb52e4c1f1636ca85","width":"1080","height":"3509"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697584051","isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":697681846,"gmtCreate":1642455004435,"gmtModify":1642455005439,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;What happened to u ISpecimen? Time to wake up.&nbsp;","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;What happened to u ISpecimen? Time to wake up.&nbsp;","text":"$iSpecimen Inc.(ISPC)$ What happened to u ISpecimen? Time to wake up.","images":[{"img":"https://static.tigerbbs.com/fbbb390b334a3a26365d60c61cb83f06","width":"1080","height":"3608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697681846","isVote":1,"tweetType":1,"viewCount":541,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":696135169,"gmtCreate":1640648423966,"gmtModify":1640648424310,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GNCA\">$Genocea Biosciences(GNCA)$</a>&nbsp;Let's rocket to the moon when trading start.","listText":"<a href=\"https://laohu8.com/S/GNCA\">$Genocea Biosciences(GNCA)$</a>&nbsp;Let's rocket to the moon when trading start.","text":"$Genocea Biosciences(GNCA)$ Let's rocket to the moon when trading start.","images":[{"img":"https://static.tigerbbs.com/bc3a56a484ce9e365dfa8f6ea49dcee1","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696135169","isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":696368951,"gmtCreate":1640619429087,"gmtModify":1640620674099,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Don't come and bullshit Stanley Morgan. Lol.&nbsp;","listText":"Don't come and bullshit Stanley Morgan. Lol.&nbsp;","text":"Don't come and bullshit Stanley Morgan. Lol.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696368951","repostId":"2194044251","repostType":2,"repost":{"id":"2194044251","pubTimestamp":1640617680,"share":"https://www.laohu8.com/m/news/2194044251?lang=&edition=full","pubTime":"2021-12-27 23:08","market":"us","language":"en","title":"Morgan Stanley Sees SoFi (SOFI) Revenues Down 2-3% on Lower Student Loan Volumes, Cuts Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2194044251","media":"StreetInsider","summary":"Morgan Stanley analyst Betsy Graseck lowered the price target to $22.00 per share from the prior $24","content":"<html><body><div>\n<div>\n<div>\n<img src=\"https://www.streetinsider.com/images/summaries/2084/resize_sofi.jpg\"/>\n</div>\n</div>\n\t\t\t\n\t\t<a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> analyst Betsy Graseck lowered the price target to $22.00 per share from the prior $24.00 on the Overweight-rated ...<br/><br/>(Premium-only article. Please sign in or upgrade to SI Premium to view.)\t</div></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Sees SoFi (SOFI) Revenues Down 2-3% on Lower Student Loan Volumes, Cuts Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Sees SoFi (SOFI) Revenues Down 2-3% on Lower Student Loan Volumes, Cuts Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 23:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19392233><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Morgan Stanley analyst Betsy Graseck lowered the price target to $22.00 per share from the prior $24.00 on the Overweight-rated ...(Premium-only article. Please sign in or upgrade to SI Premium to ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19392233\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","MS":"摩根士丹利","SOFI":"SoFi Technologies Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19392233","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194044251","content_text":"Morgan Stanley analyst Betsy Graseck lowered the price target to $22.00 per share from the prior $24.00 on the Overweight-rated ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)","news_type":1},"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696962553,"gmtCreate":1640602261751,"gmtModify":1640602464999,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon later during live trading.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon later during live trading.&nbsp;","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$ Rocket to the moon later during live trading.","images":[{"img":"https://static.tigerbbs.com/d440dbde9379067c3802c0076acd8f14","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696962553","isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":698719088,"gmtCreate":1640534604419,"gmtModify":1640534604722,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ALLK\">$Allakos Inc.(ALLK)$</a>&nbsp;to the moon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALLK\">$Allakos Inc.(ALLK)$</a>&nbsp;to the moon.&nbsp;","text":"$Allakos Inc.(ALLK)$ to the moon.","images":[{"img":"https://static.tigerbbs.com/6461b673fc8b9706b18155670fe94717","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698719088","isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":698943257,"gmtCreate":1640293905818,"gmtModify":1640293906117,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Lucky day for me. Lol.&nbsp;","listText":"Lucky day for me. Lol.&nbsp;","text":"Lucky day for me. Lol.","images":[{"img":"https://static.tigerbbs.com/a8d8aeadd0093d461bce2b912ba7b5eb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698943257","isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":691761388,"gmtCreate":1640245755786,"gmtModify":1640246797082,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon.&nbsp;","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$ Rocket to the moon.","images":[{"img":"https://static.tigerbbs.com/1706cf765e7561bb576096909a7ea9bb","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691761388","isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":691662861,"gmtCreate":1640185050086,"gmtModify":1640185050357,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691662861","repostId":"1104039472","repostType":4,"repost":{"id":"1104039472","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640184691,"share":"https://www.laohu8.com/m/news/1104039472?lang=&edition=full","pubTime":"2021-12-22 22:51","market":"us","language":"en","title":"Biogen shares fell 1.2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039472","media":"Tiger Newspress","summary":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc","content":"<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen shares fell 1.2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen shares fell 1.2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104039472","content_text":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.\nTokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.\nIn a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691689790,"gmtCreate":1640183674544,"gmtModify":1640183760696,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691689790","repostId":"1165830356","repostType":4,"repost":{"id":"1165830356","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640183188,"share":"https://www.laohu8.com/m/news/1165830356?lang=&edition=full","pubTime":"2021-12-22 22:26","market":"us","language":"en","title":"BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1165830356","media":"Benzinga","summary":"BiondVax Pharmaceuticals Ltd has entered into agreements with the Max Planck Society and the Univers","content":"<p><b>BiondVax Pharmaceuticals Ltd</b>&nbsp;has&nbsp;entered into agreements&nbsp;with the Max Planck Society and the University Medical Center Göttingen in Germany.</p>\n<ul>\n <li>The parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.</li>\n <li>VHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).</li>\n <li>These include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease &amp; lower manufacturing cost, and potential for improved patient safety.</li>\n <li>The collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.</li>\n <li>The candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.</li>\n <li>BiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.</li>\n <li>The parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.</li>\n <li><b>Price Action:</b>&nbsp;BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-22 22:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>BiondVax Pharmaceuticals Ltd</b>&nbsp;has&nbsp;entered into agreements&nbsp;with the Max Planck Society and the University Medical Center Göttingen in Germany.</p>\n<ul>\n <li>The parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.</li>\n <li>VHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).</li>\n <li>These include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease &amp; lower manufacturing cost, and potential for improved patient safety.</li>\n <li>The collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.</li>\n <li>The candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.</li>\n <li>BiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.</li>\n <li>The parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.</li>\n <li><b>Price Action:</b>&nbsp;BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165830356","content_text":"BiondVax Pharmaceuticals Ltd has entered into agreements with the Max Planck Society and the University Medical Center Göttingen in Germany.\n\nThe parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.\nVHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).\nThese include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease & lower manufacturing cost, and potential for improved patient safety.\nThe collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.\nThe candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.\nBiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.\nThe parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.\nPrice Action: BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691689864,"gmtCreate":1640183646316,"gmtModify":1640183759638,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691689864","repostId":"2193019234","repostType":4,"repost":{"id":"2193019234","pubTimestamp":1640181878,"share":"https://www.laohu8.com/m/news/2193019234?lang=&edition=full","pubTime":"2021-12-22 22:04","market":"us","language":"en","title":"France cancels order for Merck's COVID-19 antiviral drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2193019234","media":"Reuters","summary":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug fo","content":"<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck &amp; Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.</p>\n<p>France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.</p>\n<p>\"The latest studies weren't good,\" Olivier Veran told BFM TV.</p>\n<p>Merck did not immediately respond to Reuters' request for comment.</p>\n<p>While vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.</p>\n<p>France had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.</p>\n<p>The cancellation would not incur a cost, Veran said.</p>\n<p>In Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's <a href=\"https://laohu8.com/S/AONE.U\">one</a>. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.</p>\n<p>Italian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.</p>\n<p>However, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.</p>\n<p>\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.</p>\n<p>Germany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.</p>\n<p>\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.</p>\n<p>The European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.</p>\n<p>Pfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.</p>\n<p>France had purchased that drug instead, Veran said, without saying how many doses it had secured.</p>\n<p>\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>France cancels order for Merck's COVID-19 antiviral drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrance cancels order for Merck's COVID-19 antiviral drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 22:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","BK4516":"特朗普概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4007":"制药","PFE":"辉瑞","MRK":"默沙东","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓"},"source_url":"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2193019234","content_text":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.\nFrance is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.\n\"The latest studies weren't good,\" Olivier Veran told BFM TV.\nMerck did not immediately respond to Reuters' request for comment.\nWhile vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.\nFrance had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.\nThe cancellation would not incur a cost, Veran said.\nIn Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's one. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.\nItalian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.\nHowever, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.\n\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.\nGermany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.\n\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.\nThe European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.\nPfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.\nFrance had purchased that drug instead, Veran said, without saying how many doses it had secured.\n\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":699375789,"gmtCreate":1639753086868,"gmtModify":1639753087132,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Haiz.........&nbsp;","listText":"Haiz.........&nbsp;","text":"Haiz.........","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699375789","repostId":"1114105828","repostType":4,"repost":{"id":"1114105828","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639751560,"share":"https://www.laohu8.com/m/news/1114105828?lang=&edition=full","pubTime":"2021-12-17 22:32","market":"us","language":"en","title":"U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114105828","media":"Tiger Newspress","summary":"U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq ","content":"<p>U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&amp;P 500 down 0.6%.</p>\n<p>Shares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.</p>\n<p>Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.</p>\n<p>The specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.</p>\n<p>On the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.</p>\n<p>\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"</p>\n<p>\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&amp;P 500 down 0.6%.</p>\n<p>Shares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.</p>\n<p>Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.</p>\n<p>The specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.</p>\n<p>On the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.</p>\n<p>\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"</p>\n<p>\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114105828","content_text":"U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&P 500 down 0.6%.\nShares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.\nInvestors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.\nThe specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.\nOn the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.\n\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"\n\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870247608,"gmtCreate":1636627690683,"gmtModify":1636627691087,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Rocket to the moon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Rocket to the moon.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ Rocket to the moon.","images":[{"img":"https://static.tigerbbs.com/373f18ae15d2c475c5221cd2b170c23b","width":"1080","height":"2608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/870247608","isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":699372696,"gmtCreate":1639753024619,"gmtModify":1639753024885,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Omg.&nbsp;","listText":"Omg.&nbsp;","text":"Omg.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699372696","repostId":"1113440959","repostType":4,"repost":{"id":"1113440959","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752802,"share":"https://www.laohu8.com/m/news/1113440959?lang=&edition=full","pubTime":"2021-12-17 22:53","market":"us","language":"en","title":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113440959","media":"Tiger Newspress","summary":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown","content":"<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown&nbsp;Motors&nbsp;sliding&nbsp;6%&nbsp;and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown&nbsp;Motors&nbsp;sliding&nbsp;6%&nbsp;and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","GM":"通用汽车","RIVN":"Rivian Automotive, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113440959","content_text":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown Motors sliding 6% and General Motors sliding 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879669846,"gmtCreate":1636718089261,"gmtModify":1636718089376,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Rocket all the way.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;Rocket all the way.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ Rocket all the way.","images":[{"img":"https://static.tigerbbs.com/85ae77c71e74b771531a103c3a792e3a","width":"1080","height":"2608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879669846","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":691344793,"gmtCreate":1640141754786,"gmtModify":1640141755054,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon later today.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>&nbsp;Rocket to the moon later today.&nbsp;","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$ Rocket to the moon later today.","images":[{"img":"https://static.tigerbbs.com/45411e602dd7a1e02bd747fea2bad2ba","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691344793","isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":877660537,"gmtCreate":1637925348516,"gmtModify":1637925348633,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great. Thanks.&nbsp;","listText":"Great. Thanks.&nbsp;","text":"Great. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877660537","repostId":"1107826153","repostType":4,"repost":{"id":"1107826153","pubTimestamp":1637923523,"share":"https://www.laohu8.com/m/news/1107826153?lang=&edition=full","pubTime":"2021-11-26 18:45","market":"us","language":"en","title":"5 Stocks To Watch For November 26, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1107826153","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Pinduoduo Inc. to re","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Pinduoduo Inc.</b>&nbsp;to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. Pinduoduo shares rose 0.8% to $82.00 in after-hours trading.</li>\n <li><b>Global Cord Blood Corporation</b>&nbsp;reported that its revenue for the second quarter climbed 9.8% year-over-year to RMB313.7 million ($48.7 million). Net income attributable to shareholders, however, fell 4.3% to RMB125.7 million ($19.5 million) last quarter. Global Cord Blood shares fell 0.7% to $4.22 in the after-hours trading session.</li>\n <li>Analysts expect&nbsp;<b>BlueCity Holdings Limited</b>&nbsp;to post a quarterly loss at $0.14 per share on revenue of $51.21 billion before the opening bell. BlueCity shares gained 2.5% to $2.48 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b>Selecta Biosciences</b>&nbsp;disclosed that the FDA has issued clinical hold on its Phase 1/2 clinical trial of SEL-302 due to CMC related questions. Selecta Biosciences shares dipped 14.8% to $2.71 in the after-hours trading session.</li>\n <li><b>CVB Financial Corp.</b>, the holding company for Citizens Business Bank, disclosed that Citizens received regulatory approvals to complete its merger with Suncrest Bank. CVB Financial shares fell 1.4% to close at $20.65 on Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 26, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 26, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 18:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Some of the stocks that may grab investor focus today are:\n\nWall Street expects Pinduoduo Inc. to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVBF":"CVB金融","BLCT":"蓝城兄弟","PDD":"拼多多"},"source_url":"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107826153","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Pinduoduo Inc. to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. Pinduoduo shares rose 0.8% to $82.00 in after-hours trading.\nGlobal Cord Blood Corporation reported that its revenue for the second quarter climbed 9.8% year-over-year to RMB313.7 million ($48.7 million). Net income attributable to shareholders, however, fell 4.3% to RMB125.7 million ($19.5 million) last quarter. Global Cord Blood shares fell 0.7% to $4.22 in the after-hours trading session.\nAnalysts expect BlueCity Holdings Limited to post a quarterly loss at $0.14 per share on revenue of $51.21 billion before the opening bell. BlueCity shares gained 2.5% to $2.48 in after-hours trading.\n\n\nSelecta Biosciences disclosed that the FDA has issued clinical hold on its Phase 1/2 clinical trial of SEL-302 due to CMC related questions. Selecta Biosciences shares dipped 14.8% to $2.71 in the after-hours trading session.\nCVB Financial Corp., the holding company for Citizens Business Bank, disclosed that Citizens received regulatory approvals to complete its merger with Suncrest Bank. CVB Financial shares fell 1.4% to close at $20.65 on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691662861,"gmtCreate":1640185050086,"gmtModify":1640185050357,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691662861","repostId":"1104039472","repostType":4,"repost":{"id":"1104039472","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640184691,"share":"https://www.laohu8.com/m/news/1104039472?lang=&edition=full","pubTime":"2021-12-22 22:51","market":"us","language":"en","title":"Biogen shares fell 1.2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039472","media":"Tiger Newspress","summary":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc","content":"<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen shares fell 1.2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen shares fell 1.2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104039472","content_text":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.\nTokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.\nIn a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691689790,"gmtCreate":1640183674544,"gmtModify":1640183760696,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691689790","repostId":"1165830356","repostType":4,"repost":{"id":"1165830356","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640183188,"share":"https://www.laohu8.com/m/news/1165830356?lang=&edition=full","pubTime":"2021-12-22 22:26","market":"us","language":"en","title":"BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1165830356","media":"Benzinga","summary":"BiondVax Pharmaceuticals Ltd has entered into agreements with the Max Planck Society and the Univers","content":"<p><b>BiondVax Pharmaceuticals Ltd</b>&nbsp;has&nbsp;entered into agreements&nbsp;with the Max Planck Society and the University Medical Center Göttingen in Germany.</p>\n<ul>\n <li>The parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.</li>\n <li>VHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).</li>\n <li>These include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease &amp; lower manufacturing cost, and potential for improved patient safety.</li>\n <li>The collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.</li>\n <li>The candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.</li>\n <li>BiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.</li>\n <li>The parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.</li>\n <li><b>Price Action:</b>&nbsp;BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-22 22:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>BiondVax Pharmaceuticals Ltd</b>&nbsp;has&nbsp;entered into agreements&nbsp;with the Max Planck Society and the University Medical Center Göttingen in Germany.</p>\n<ul>\n <li>The parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.</li>\n <li>VHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).</li>\n <li>These include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease &amp; lower manufacturing cost, and potential for improved patient safety.</li>\n <li>The collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.</li>\n <li>The candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.</li>\n <li>BiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.</li>\n <li>The parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.</li>\n <li><b>Price Action:</b>&nbsp;BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165830356","content_text":"BiondVax Pharmaceuticals Ltd has entered into agreements with the Max Planck Society and the University Medical Center Göttingen in Germany.\n\nThe parties intend to enter into a 5-year strategic research collaboration, including an option for BiondVax to license VHH antibodies.\nVHH antibodies were developed by the Max Planck Institute and exhibit key advantages over current industry-standard human monoclonal antibodies (mAbs).\nThese include the ability to bind to smaller target sites, significantly higher affinity to the target, higher stability, ease & lower manufacturing cost, and potential for improved patient safety.\nThe collaboration will begin with licensing BiondVax's exclusive worldwide COVID-19 VHH antibody candidates.\nThe candidates have been shown to neutralize all known major variants of concern at around 100-times lower drug concentrations than current COVID-19 mAbs.\nBiondVax anticipates completing preclinical proof-of-concept inhalation studies in 2022 and initiating human clinical trials in 2023.\nThe parties aim to complete definitive agreements within 90 days, although there is no guarantee if and when the parties will execute the final agreements.\nPrice Action: BVXV shares are up 98.7% at $2.94 during the premarket session on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690155063,"gmtCreate":1639648958665,"gmtModify":1639648968689,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690155063","repostId":"1174747764","repostType":4,"repost":{"id":"1174747764","pubTimestamp":1639648142,"share":"https://www.laohu8.com/m/news/1174747764?lang=&edition=full","pubTime":"2021-12-16 17:49","market":"us","language":"en","title":"Tesla Bags Top-Rated EV Badge From Edmunds, Rivian Gets Editor's Choice Crown","url":"https://stock-news.laohu8.com/highlight/detail?id=1174747764","media":"Benzinga","summary":"Tesla Inc and Rivian Automotive Inc have secured top awards from automotive research agency Edmunds ","content":"<p><b>Tesla Inc</b>&nbsp;and&nbsp;<b>Rivian Automotive Inc</b>&nbsp;have secured top awards from&nbsp;automotive research agency&nbsp;Edmunds as part of its 2022 rankings.</p>\n<p><b>What Happened:</b>&nbsp;Tesla’s affordable, compact sedan Model 3 has been named the top-rated electric vehicle of the year and the recently launched R1T electric pickup truck from Rivian has been crowned the editor’s choice award.</p>\n<p>Model 3 has now bagged&nbsp;the title for three years in a row, the research agency said.</p>\n<p>“The first all-electric pickup truck to market, it offers an impressive combination of on- and off-road performance, cutting-edge technology and thoughtful utility,” Edmunds said on why R1T bagged editor’s choice award.</p>\n<p>The recently-listed Rivian is backed by&nbsp;<b>Amazon.com Inc</b>&nbsp;and&nbsp;<b>Ford Motor Co</b>. The pre-revenue electric automaker has&nbsp;delivered just 156 electric vehicles but has secured a higher valuation than legacy rivals Ford and&nbsp;<b>General Motors Co</b>.</p>\n<p>The development comes on the heels of Tesla CEO&nbsp;<b>Elon Musk</b>&nbsp;securing two back-to-back Person of The Year awards this week.</p>\n<p><b>Author's Take:</b>Tesla has disrupted the automotive&nbsp;sector&nbsp;with electric vehicles despite resistance from traditional players.</p>\n<p>Those results are now showing as the entire industry, under pressure from governments and consumers, is taking big steps to shift to an all-electric future.</p>\n<p><b>Price Action:</b>Tesla shares closed 1.82% higher at $975.99 a share on Wednesday.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Bags Top-Rated EV Badge From Edmunds, Rivian Gets Editor's Choice Crown</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Bags Top-Rated EV Badge From Edmunds, Rivian Gets Editor's Choice Crown\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 17:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24637741/tesla-bags-top-rated-ev-badge-from-edmunds-rivian-gets-editors-choice-crown><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Inc and Rivian Automotive Inc have secured top awards from automotive research agency Edmunds as part of its 2022 rankings.\nWhat Happened: Tesla’s affordable, compact sedan Model 3 has been ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24637741/tesla-bags-top-rated-ev-badge-from-edmunds-rivian-gets-editors-choice-crown\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/12/24637741/tesla-bags-top-rated-ev-badge-from-edmunds-rivian-gets-editors-choice-crown","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174747764","content_text":"Tesla Inc and Rivian Automotive Inc have secured top awards from automotive research agency Edmunds as part of its 2022 rankings.\nWhat Happened: Tesla’s affordable, compact sedan Model 3 has been named the top-rated electric vehicle of the year and the recently launched R1T electric pickup truck from Rivian has been crowned the editor’s choice award.\nModel 3 has now bagged the title for three years in a row, the research agency said.\n“The first all-electric pickup truck to market, it offers an impressive combination of on- and off-road performance, cutting-edge technology and thoughtful utility,” Edmunds said on why R1T bagged editor’s choice award.\nThe recently-listed Rivian is backed by Amazon.com Inc and Ford Motor Co. The pre-revenue electric automaker has delivered just 156 electric vehicles but has secured a higher valuation than legacy rivals Ford and General Motors Co.\nThe development comes on the heels of Tesla CEO Elon Musk securing two back-to-back Person of The Year awards this week.\nAuthor's Take:Tesla has disrupted the automotive sector with electric vehicles despite resistance from traditional players.\nThose results are now showing as the entire industry, under pressure from governments and consumers, is taking big steps to shift to an all-electric future.\nPrice Action:Tesla shares closed 1.82% higher at $975.99 a share on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874003750,"gmtCreate":1637708873885,"gmtModify":1637708874003,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>&nbsp;up up to the moon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>&nbsp;up up to the moon.&nbsp;","text":"$Lucid Group Inc(LCID)$ up up to the moon.","images":[{"img":"https://static.tigerbbs.com/56ba0b3bde97fbde3425c09d7ba7944d","width":"1080","height":"3650"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874003750","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":879409410,"gmtCreate":1636759391488,"gmtModify":1636759391598,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GGPI\">$Gores Guggenheim Inc(GGPI)$</a>&nbsp;Rocketing very soon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/GGPI\">$Gores Guggenheim Inc(GGPI)$</a>&nbsp;Rocketing very soon.&nbsp;","text":"$Gores Guggenheim Inc(GGPI)$ Rocketing very soon.","images":[{"img":"https://static.tigerbbs.com/64626887e1b887b2fa8851d7c229d30a","width":"1080","height":"2608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879409410","isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690806594,"gmtCreate":1639651600724,"gmtModify":1639651601022,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690806594","repostId":"1184616731","repostType":4,"repost":{"id":"1184616731","pubTimestamp":1639650290,"share":"https://www.laohu8.com/m/news/1184616731?lang=&edition=full","pubTime":"2021-12-16 18:24","market":"us","language":"en","title":"Stocks Set to Extend Gains Ahead of More Central Bank Decisions","url":"https://stock-news.laohu8.com/highlight/detail?id=1184616731","media":"WSJ","summary":"Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank o","content":"<p>Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.</p>\n<p>Futures for the S&amp;P 500 rose 0.5% Thursday, a day after the broad stocks gauge closed at its second-highest level on record. Contracts for the Dow Jones Industrial Average added 0.4% and Nasdaq-100 futures climbed 0.6%, pointing to a strong start to the session for technology stocks.</p>\n<p>Brent-crude futures, the benchmark in international oil markets, rose 0.9% to $74.51 a barrel. Yields on 10-year Treasury notes ticked down to 1.451% Thursday from 1.460% Wednesday. Yields move in the opposite direction to bond prices and barely moved in response to the Fed’s shift to tighten monetary policy.</p>\n<p>Stocks rallied when the central bank completed that pivot Wednesday, approving plans to end a program of asset purchases by March and penciling in three rate rises in 2022. Investors said the change of stance—ending months in which the Fed said higher inflation would fade—removed the risk of runaway growth in consumer prices.</p>\n<p>“There’s a goldilocks interpretation,” said Edward Park, chief investment officer at Brooks Macdonald, referring to a situation in which the Fed tames inflation but doesn’t push rates high enough to kill the economic recovery.</p>\n<p>Mr. Park said stocks are likely to keep rising through to year end. “You have people saying, you know, it’s painful being in fixed income or cash.”</p>\n<p>European stock markets followed Wall Street higher Thursday. The pan-continental Stoxx Europe 600 rose 1.4%, led by tech, energy, travel and leisure stocks.</p>\n<p>Turkey’s currency crisis deepened ahead of a potential interest-rate cut by the central bank, which has come under pressure from President Recep Tayyip Erdogan to lower borrowing costs. The lira weakened 2.5% to trade at 15.18 per dollar.</p>\n<p>Like the U.S., the eurozone and the U.K. are experiencing their highest inflation in years. Central banks there are also contending with waves of coronavirus infections that complicate the outlook for consumer prices and economic growth.</p>\n<p>The Bank of England, which will publish its decision at 7 a.m. ET, was until recently expected to raise interest rates Thursday. However, a jump in Covid-19 cases driven by the Omicron variant might encourage the central bank to keep policy on hold, Mr. Park said. The pound rose 0.2% to $1.3293 before the decision.</p>\n<p>The European Central Bank, meanwhile, is expected to signal that it will continue buying bonds for some time, and that it won’t increase interest rates next year. The central bank is due to publish its decision at 7:45 a.m. The euro traded 0.2% higher at $1.1316.</p>\n<p>Investors will parse surveys of purchasing managers in the U.S. and Europe for evidence of the extent to which rising coronavirus cases have knocked economic growth. The reports—due at 9:45 a.m. for the U.S.—are expected to show factory output is growing, though at a slower pace than in November.</p>\n<p>In individual European stock moves, Novartis rose 4.3% after the Swiss pharmaceutical firm said it would use the proceeds from the recent sale of its stake in Roche to buy back up to $15 billion of its shares. Food-delivery firms Just Eat Takeaway.com and Delivery Hero both rose more than 5%. Électricité de France dropped 11% after the French utility cut earnings forecasts to reflect the safety-related outages at nuclear-power plants.</p>\n<p>In Asia, Japan’s Nikkei 225 gained 2.1%, the Shanghai Composite Index rose 0.8% and Hong Kong’s Hang Seng added 0.2%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks Set to Extend Gains Ahead of More Central Bank Decisions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Set to Extend Gains Ahead of More Central Bank Decisions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 18:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1><strong>WSJ</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.\nFutures for the S&...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184616731","content_text":"Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.\nFutures for the S&P 500 rose 0.5% Thursday, a day after the broad stocks gauge closed at its second-highest level on record. Contracts for the Dow Jones Industrial Average added 0.4% and Nasdaq-100 futures climbed 0.6%, pointing to a strong start to the session for technology stocks.\nBrent-crude futures, the benchmark in international oil markets, rose 0.9% to $74.51 a barrel. Yields on 10-year Treasury notes ticked down to 1.451% Thursday from 1.460% Wednesday. Yields move in the opposite direction to bond prices and barely moved in response to the Fed’s shift to tighten monetary policy.\nStocks rallied when the central bank completed that pivot Wednesday, approving plans to end a program of asset purchases by March and penciling in three rate rises in 2022. Investors said the change of stance—ending months in which the Fed said higher inflation would fade—removed the risk of runaway growth in consumer prices.\n“There’s a goldilocks interpretation,” said Edward Park, chief investment officer at Brooks Macdonald, referring to a situation in which the Fed tames inflation but doesn’t push rates high enough to kill the economic recovery.\nMr. Park said stocks are likely to keep rising through to year end. “You have people saying, you know, it’s painful being in fixed income or cash.”\nEuropean stock markets followed Wall Street higher Thursday. The pan-continental Stoxx Europe 600 rose 1.4%, led by tech, energy, travel and leisure stocks.\nTurkey’s currency crisis deepened ahead of a potential interest-rate cut by the central bank, which has come under pressure from President Recep Tayyip Erdogan to lower borrowing costs. The lira weakened 2.5% to trade at 15.18 per dollar.\nLike the U.S., the eurozone and the U.K. are experiencing their highest inflation in years. Central banks there are also contending with waves of coronavirus infections that complicate the outlook for consumer prices and economic growth.\nThe Bank of England, which will publish its decision at 7 a.m. ET, was until recently expected to raise interest rates Thursday. However, a jump in Covid-19 cases driven by the Omicron variant might encourage the central bank to keep policy on hold, Mr. Park said. The pound rose 0.2% to $1.3293 before the decision.\nThe European Central Bank, meanwhile, is expected to signal that it will continue buying bonds for some time, and that it won’t increase interest rates next year. The central bank is due to publish its decision at 7:45 a.m. The euro traded 0.2% higher at $1.1316.\nInvestors will parse surveys of purchasing managers in the U.S. and Europe for evidence of the extent to which rising coronavirus cases have knocked economic growth. The reports—due at 9:45 a.m. for the U.S.—are expected to show factory output is growing, though at a slower pace than in November.\nIn individual European stock moves, Novartis rose 4.3% after the Swiss pharmaceutical firm said it would use the proceeds from the recent sale of its stake in Roche to buy back up to $15 billion of its shares. Food-delivery firms Just Eat Takeaway.com and Delivery Hero both rose more than 5%. Électricité de France dropped 11% after the French utility cut earnings forecasts to reflect the safety-related outages at nuclear-power plants.\nIn Asia, Japan’s Nikkei 225 gained 2.1%, the Shanghai Composite Index rose 0.8% and Hong Kong’s Hang Seng added 0.2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690154938,"gmtCreate":1639649013026,"gmtModify":1639649013329,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow.....&nbsp;","listText":"Wow.....&nbsp;","text":"Wow.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690154938","repostId":"1171817404","repostType":4,"repost":{"id":"1171817404","pubTimestamp":1639648605,"share":"https://www.laohu8.com/m/news/1171817404?lang=&edition=full","pubTime":"2021-12-16 17:56","market":"us","language":"en","title":"46 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1171817404","media":"Benzinga","summary":"Gainers\n\nTheseus Pharmaceuticals, Inc. gained 34.1% to settle at $12.58 on Wednesday.\nCMC Materials,","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Theseus Pharmaceuticals, Inc.</b>&nbsp;gained 34.1% to settle at $12.58 on Wednesday.</li>\n <li><b>CMC Materials, Inc.</b>&nbsp;climbed 33.9% to close at $195.50 on Wednesday after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock.</li>\n <li><b>Biofrontera Inc.</b>&nbsp;shares jumped 26.4% to settle at $6.95 on Wednesday after Benchmark initiated coverage on the stock with a Buy rating and announced a $11 price target.</li>\n <li><b>Regional Health Properties, Inc.</b>&nbsp;gained 23.8% to close at $6.70.Regional Health Props, last month, posted a Q3 loss of $1.25 per share.</li>\n <li><b>Gemini Therapeutics, Inc.</b>&nbsp;rose 23.1% to settle at $2.99 after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and a $20 price target.</li>\n <li><b>CN Energy Group. Inc.</b>&nbsp;jumped 22.4% to close at $3.01.</li>\n <li><b>Mesoblast Limited</b>&nbsp;climbed 19.2% to settle at $4.97. Mesoblast shares dropped around 28% on Tuesday after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing.</li>\n <li><b>Broadstone Acquisition Corp.</b>&nbsp;gained 19.1% to close at $10.68.</li>\n <li><b>Cabaletta Bio, Inc.</b>&nbsp;jumped 18.2% to settle at $3.97.</li>\n <li><b>Ensysce Biosciences, Inc.</b>&nbsp;surged 17.4% to close at $4.11. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.</li>\n <li><b>Trio-Tech International</b>&nbsp;gained 16.6% to close at $9.42.</li>\n <li><b>Aerovate Therapeutics, Inc.</b>&nbsp;jumped 16.3% to close at $12.34 after the company announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.</li>\n <li><b>Optical Cable Corporation</b>&nbsp;gained 16.2% to settle at $6.40.</li>\n <li><b>Conn's, Inc.</b>&nbsp;rose 16.1% to close at $20.81. Conn's Board of Directors authorized a repurchase program of $150 million of its outstanding stock.</li>\n <li><b>Design Therapeutics, Inc.</b>&nbsp;surged 16% to settle at $20.36.</li>\n <li><b>Bird Global, Inc.</b>&nbsp;gained 15.7% to close at $8.97.</li>\n <li><b>VerifyMe, Inc.</b>&nbsp;jumped 13.7% to close at $3.65.</li>\n <li><b>East Stone Acquisition Corporation</b>&nbsp;gained 12.9% to close at $15.24 after declining 26% on Tuesday.</li>\n <li><b>Vir Biotechnology, Inc.</b>&nbsp;gained 12.1% to close at $51.62 after the company announced new preclinical data demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant.</li>\n <li><b>SeaChange International, Inc.</b>&nbsp;rose 11.9% to close at $1.69 after the company reported better-than-expected Q3 results.</li>\n <li><b>Nxt-ID, Inc.</b>&nbsp;shares rose 11.7% to close at $2.78 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.</li>\n <li><b>Tandem Diabetes Care, Inc.</b>&nbsp;climbed 10.5% to close at $144.34.</li>\n <li><b>Eli Lilly and Company</b>&nbsp;climbed 10.4% to close at $275.28 after the company issued FY21 EPS guidance above analyst estimates.</li>\n <li><b>Borr Drilling Limited</b>&nbsp;gained 9.2% to close at $1.67 after declining over 4% on Tuesday..</li>\n <li><b>Galera Therapeutics, Inc.</b>&nbsp;gained 7.4% to close at $2.90 after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target. Galera Therapeutics shares jumped around 96% on Tuesday after the company announced the primary endpoint met statistical significance in corrected topline efficacy data of Phase 3 ROMAN trial of avasopasem.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Atai Life Sciences N.V.</b>&nbsp;dropped 31.9% to close at $6.82 on Wednesday.</li>\n <li><b>China Xiangtai Food Co., Ltd.</b>&nbsp;fell 28.2% to settle at $1.81. The company earlier announced the completion of its first purchase of spot Bitcoin miners worth $7 million.</li>\n <li><b>Aspen Group, Inc.</b>&nbsp;shares declined 27.2% to close at $1.90 on Wednesday after the company reported worse-than-expected Q2 results and cut FY22 guidance.</li>\n <li><b>REV Group, Inc.</b>&nbsp;fell 25.5% to close at $11.87 after the company reported worse-than-expected Q4 EPS and sales results and issued FY22 sales guidance below estimates.</li>\n <li><b>Idera Pharmaceuticals, Inc.</b>&nbsp;shares dipped 25.3% to close at $0.6501 on Wednesday after the company announced tilsotolimod updates. The company said no further enrollment in ILLUMINATE-206 trial is planned at this point.</li>\n <li><b>LianBio</b>&nbsp;fell 21.3% to close at $7.68. LianBio reported a Q3 loss of $0.63 per share.</li>\n <li><b>The Oncology Institute, Inc.</b>&nbsp;fell 17.9% to close at $6.25.</li>\n <li><b>Alzamend Neuro, Inc.</b>&nbsp;fell 15.9% to close at $2.59 after jumping 28% on Tuesday.</li>\n <li><b>LogicBio Therapeutics, Inc</b>&nbsp;dropped 15.5% to close at $2.45. Barclays maintained LogicBio Therapeutics with an Overweight and lowered the price target from $24 to $8.</li>\n <li><b>Legend Biotech Corporation</b>&nbsp;shares fell 15.3% to close at $41.14 after the company reported an offering of $300 million in ADSs.</li>\n <li><b>Huadi International Group Co., Ltd.</b>&nbsp;fell 15% to close at $27.62.</li>\n <li><b>iSpecimen Inc.</b>&nbsp;fell 13.3% to close at $10.87.</li>\n <li><b>MIND Technology, Inc.</b>&nbsp;shares fell 12.9% to close at $1.55. MIND Technology shares gained 30% on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division.</li>\n <li><b>Adagio Therapeutics, Inc.</b>&nbsp;fell 12.5% to close at $6.35 after Stifel downgraded the stock from Buy to Hold and lowered the price target from $50 to $9. Adagio Therapeutics shares dipped 79% on Tuesday after the company said based on the in vitro findings related to Omicron, it plans to pause patient recruitment in its Phase 2/3 COVID-19 treatment trial at clinical sites in South Africa.</li>\n <li><b>Zai Lab Limited</b>&nbsp;fell 12.4% to close at $54.90.</li>\n <li><b>Cerence Inc.</b>&nbsp;dropped 11.4% to close at $69.20. Cerence’s board promoted Dr. Stefan Ortmanns to Chief Executive Officer and Director.</li>\n <li><b>ABM Industries Incorporated</b>&nbsp;fell 11% to close at $40.88 as the company reported fourth-quarter revenue growth of 14.2% year-over-year to $1.69 billion, comprised of 7.4% organic growth and 6.8% from acquisition.</li>\n <li><b>BeiGene, Ltd.</b>&nbsp;fell 10.7% to close at $248.56. BeiGene reported authorisation of BRUKINSA (zanubrutinib) from the UK’s MHRA for the treatment of adults with Waldenström’s Macroglobulinemia in Great Britain.</li>\n <li><b>Cooper-Standard Holdings Inc.</b>&nbsp;fell 7.1% to close at $19.71.</li>\n <li><b>Nisun International Enterprise Development Group Co., Ltd</b>&nbsp;fell 6.9% to close at $3.50.</li>\n <li><b>I-Mab</b>&nbsp;fell 5% to close at $46.97. I-Mab received IND approval for Phase 1 clinical trial of bispecific antibody TJ-CD4B in solid tumors in China.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>46 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n46 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 17:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24638543/46-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nTheseus Pharmaceuticals, Inc. gained 34.1% to settle at $12.58 on Wednesday.\nCMC Materials, Inc. climbed 33.9% to close at $195.50 on Wednesday after the company announced it will be acquired...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24638543/46-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BGNE":"百济神州","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24638543/46-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171817404","content_text":"Gainers\n\nTheseus Pharmaceuticals, Inc. gained 34.1% to settle at $12.58 on Wednesday.\nCMC Materials, Inc. climbed 33.9% to close at $195.50 on Wednesday after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock.\nBiofrontera Inc. shares jumped 26.4% to settle at $6.95 on Wednesday after Benchmark initiated coverage on the stock with a Buy rating and announced a $11 price target.\nRegional Health Properties, Inc. gained 23.8% to close at $6.70.Regional Health Props, last month, posted a Q3 loss of $1.25 per share.\nGemini Therapeutics, Inc. rose 23.1% to settle at $2.99 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target.\nCN Energy Group. Inc. jumped 22.4% to close at $3.01.\nMesoblast Limited climbed 19.2% to settle at $4.97. Mesoblast shares dropped around 28% on Tuesday after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing.\nBroadstone Acquisition Corp. gained 19.1% to close at $10.68.\nCabaletta Bio, Inc. jumped 18.2% to settle at $3.97.\nEnsysce Biosciences, Inc. surged 17.4% to close at $4.11. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.\nTrio-Tech International gained 16.6% to close at $9.42.\nAerovate Therapeutics, Inc. jumped 16.3% to close at $12.34 after the company announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.\nOptical Cable Corporation gained 16.2% to settle at $6.40.\nConn's, Inc. rose 16.1% to close at $20.81. Conn's Board of Directors authorized a repurchase program of $150 million of its outstanding stock.\nDesign Therapeutics, Inc. surged 16% to settle at $20.36.\nBird Global, Inc. gained 15.7% to close at $8.97.\nVerifyMe, Inc. jumped 13.7% to close at $3.65.\nEast Stone Acquisition Corporation gained 12.9% to close at $15.24 after declining 26% on Tuesday.\nVir Biotechnology, Inc. gained 12.1% to close at $51.62 after the company announced new preclinical data demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant.\nSeaChange International, Inc. rose 11.9% to close at $1.69 after the company reported better-than-expected Q3 results.\nNxt-ID, Inc. shares rose 11.7% to close at $2.78 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.\nTandem Diabetes Care, Inc. climbed 10.5% to close at $144.34.\nEli Lilly and Company climbed 10.4% to close at $275.28 after the company issued FY21 EPS guidance above analyst estimates.\nBorr Drilling Limited gained 9.2% to close at $1.67 after declining over 4% on Tuesday..\nGalera Therapeutics, Inc. gained 7.4% to close at $2.90 after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target. Galera Therapeutics shares jumped around 96% on Tuesday after the company announced the primary endpoint met statistical significance in corrected topline efficacy data of Phase 3 ROMAN trial of avasopasem.\n\nLosers\n\nAtai Life Sciences N.V. dropped 31.9% to close at $6.82 on Wednesday.\nChina Xiangtai Food Co., Ltd. fell 28.2% to settle at $1.81. The company earlier announced the completion of its first purchase of spot Bitcoin miners worth $7 million.\nAspen Group, Inc. shares declined 27.2% to close at $1.90 on Wednesday after the company reported worse-than-expected Q2 results and cut FY22 guidance.\nREV Group, Inc. fell 25.5% to close at $11.87 after the company reported worse-than-expected Q4 EPS and sales results and issued FY22 sales guidance below estimates.\nIdera Pharmaceuticals, Inc. shares dipped 25.3% to close at $0.6501 on Wednesday after the company announced tilsotolimod updates. The company said no further enrollment in ILLUMINATE-206 trial is planned at this point.\nLianBio fell 21.3% to close at $7.68. LianBio reported a Q3 loss of $0.63 per share.\nThe Oncology Institute, Inc. fell 17.9% to close at $6.25.\nAlzamend Neuro, Inc. fell 15.9% to close at $2.59 after jumping 28% on Tuesday.\nLogicBio Therapeutics, Inc dropped 15.5% to close at $2.45. Barclays maintained LogicBio Therapeutics with an Overweight and lowered the price target from $24 to $8.\nLegend Biotech Corporation shares fell 15.3% to close at $41.14 after the company reported an offering of $300 million in ADSs.\nHuadi International Group Co., Ltd. fell 15% to close at $27.62.\niSpecimen Inc. fell 13.3% to close at $10.87.\nMIND Technology, Inc. shares fell 12.9% to close at $1.55. MIND Technology shares gained 30% on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division.\nAdagio Therapeutics, Inc. fell 12.5% to close at $6.35 after Stifel downgraded the stock from Buy to Hold and lowered the price target from $50 to $9. Adagio Therapeutics shares dipped 79% on Tuesday after the company said based on the in vitro findings related to Omicron, it plans to pause patient recruitment in its Phase 2/3 COVID-19 treatment trial at clinical sites in South Africa.\nZai Lab Limited fell 12.4% to close at $54.90.\nCerence Inc. dropped 11.4% to close at $69.20. Cerence’s board promoted Dr. Stefan Ortmanns to Chief Executive Officer and Director.\nABM Industries Incorporated fell 11% to close at $40.88 as the company reported fourth-quarter revenue growth of 14.2% year-over-year to $1.69 billion, comprised of 7.4% organic growth and 6.8% from acquisition.\nBeiGene, Ltd. fell 10.7% to close at $248.56. BeiGene reported authorisation of BRUKINSA (zanubrutinib) from the UK’s MHRA for the treatment of adults with Waldenström’s Macroglobulinemia in Great Britain.\nCooper-Standard Holdings Inc. fell 7.1% to close at $19.71.\nNisun International Enterprise Development Group Co., Ltd fell 6.9% to close at $3.50.\nI-Mab fell 5% to close at $46.97. I-Mab received IND approval for Phase 1 clinical trial of bispecific antibody TJ-CD4B in solid tumors in China.","news_type":1},"isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607418628,"gmtCreate":1639578109268,"gmtModify":1639578466406,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;What happened to u SoFi darling? Are u sick? Lol.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;What happened to u SoFi darling? Are u sick? Lol.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ What happened to u SoFi darling? Are u sick? Lol.","images":[{"img":"https://static.tigerbbs.com/3a16964edd776815c55ea999261a615a","width":"1080","height":"3608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607418628","isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":609918932,"gmtCreate":1638230837353,"gmtModify":1638230837792,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;up up rocket to the moon.&nbsp;","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>&nbsp;up up rocket to the moon.&nbsp;","text":"$iSpecimen Inc.(ISPC)$ up up rocket to the moon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609918932","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876082183,"gmtCreate":1637244661148,"gmtModify":1637244661261,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GGPI\">$Gores Guggenheim Inc(GGPI)$</a>&nbsp;all the way&nbsp;","listText":"<a href=\"https://laohu8.com/S/GGPI\">$Gores Guggenheim Inc(GGPI)$</a>&nbsp;all the way&nbsp;","text":"$Gores Guggenheim Inc(GGPI)$ all the way","images":[{"img":"https://static.tigerbbs.com/f9ce317adf5e3e0574bdfbaa6af5d79c","width":"1080","height":"3650"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876082183","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":873730755,"gmtCreate":1636985624088,"gmtModify":1636985624197,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great.&nbsp;","listText":"Great.&nbsp;","text":"Great.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873730755","repostId":"1153060760","repostType":4,"repost":{"id":"1153060760","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636985299,"share":"https://www.laohu8.com/m/news/1153060760?lang=&edition=full","pubTime":"2021-11-15 22:08","market":"us","language":"en","title":"Burger King parent to buy Firehouse Subs for $1 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1153060760","media":"Tiger Newspress","summary":"Burger King-parent Restaurant Brands International Inc(QSR.TO)said on Monday it would buy Firehouse ","content":"<p>Burger King-parent Restaurant Brands International Inc(QSR.TO)said on Monday it would buy Firehouse Subs for $1 billion in an all-cash deal as it adds the U.S. sandwich chain to its roster of popular outlets, including Tim Hortons and Popeyes.</p>\n<p>The deal would immediately add to Restaurant Brands' earnings, the company said.</p>\n<p>Jacksonville, Florida-based Firehouse Subs' system-wide sales would be about $1.1 billion for 2021, with October U.S. same-store sales about 20% higher from pre-pandemic levels two years ago, Restaurant Brands said.</p>\n<p>Restaurant Brands said it planned to fund the deal, expected to close in the coming months, through a combination of cash on hand and debt.</p>\n<p>Its&nbsp;shares&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/6b6aec954f9d72ed828f05646f2f3a41\" tg-width=\"776\" tg-height=\"562\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Burger King parent to buy Firehouse Subs for $1 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBurger King parent to buy Firehouse Subs for $1 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-15 22:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Burger King-parent Restaurant Brands International Inc(QSR.TO)said on Monday it would buy Firehouse Subs for $1 billion in an all-cash deal as it adds the U.S. sandwich chain to its roster of popular outlets, including Tim Hortons and Popeyes.</p>\n<p>The deal would immediately add to Restaurant Brands' earnings, the company said.</p>\n<p>Jacksonville, Florida-based Firehouse Subs' system-wide sales would be about $1.1 billion for 2021, with October U.S. same-store sales about 20% higher from pre-pandemic levels two years ago, Restaurant Brands said.</p>\n<p>Restaurant Brands said it planned to fund the deal, expected to close in the coming months, through a combination of cash on hand and debt.</p>\n<p>Its&nbsp;shares&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/6b6aec954f9d72ed828f05646f2f3a41\" tg-width=\"776\" tg-height=\"562\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSR":"餐饮品牌国际"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153060760","content_text":"Burger King-parent Restaurant Brands International Inc(QSR.TO)said on Monday it would buy Firehouse Subs for $1 billion in an all-cash deal as it adds the U.S. sandwich chain to its roster of popular outlets, including Tim Hortons and Popeyes.\nThe deal would immediately add to Restaurant Brands' earnings, the company said.\nJacksonville, Florida-based Firehouse Subs' system-wide sales would be about $1.1 billion for 2021, with October U.S. same-store sales about 20% higher from pre-pandemic levels two years ago, Restaurant Brands said.\nRestaurant Brands said it planned to fund the deal, expected to close in the coming months, through a combination of cash on hand and debt.\nIts shares jumped over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691689864,"gmtCreate":1640183646316,"gmtModify":1640183759638,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691689864","repostId":"2193019234","repostType":4,"repost":{"id":"2193019234","pubTimestamp":1640181878,"share":"https://www.laohu8.com/m/news/2193019234?lang=&edition=full","pubTime":"2021-12-22 22:04","market":"us","language":"en","title":"France cancels order for Merck's COVID-19 antiviral drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2193019234","media":"Reuters","summary":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug fo","content":"<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck &amp; Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.</p>\n<p>France is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.</p>\n<p>\"The latest studies weren't good,\" Olivier Veran told BFM TV.</p>\n<p>Merck did not immediately respond to Reuters' request for comment.</p>\n<p>While vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.</p>\n<p>France had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.</p>\n<p>The cancellation would not incur a cost, Veran said.</p>\n<p>In Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's <a href=\"https://laohu8.com/S/AONE.U\">one</a>. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.</p>\n<p>Italian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.</p>\n<p>However, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.</p>\n<p>\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.</p>\n<p>Germany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.</p>\n<p>\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.</p>\n<p>The European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.</p>\n<p>Pfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.</p>\n<p>France had purchased that drug instead, Veran said, without saying how many doses it had secured.</p>\n<p>\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>France cancels order for Merck's COVID-19 antiviral drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrance cancels order for Merck's COVID-19 antiviral drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 22:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","BK4516":"特朗普概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4007":"制药","PFE":"辉瑞","MRK":"默沙东","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓"},"source_url":"https://finance.yahoo.com/news/1-france-cancels-order-mercks-135238223.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2193019234","content_text":"PARIS, Dec 22 (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday.\nFrance is the first country to publicly say it has cancelled an order for the Merck treatment after the company released data in late November suggesting its drug was markedly less effective than previously thought, reducing hospitalisations and deaths in its clinical trial of high-risk individuals by about 30%.\n\"The latest studies weren't good,\" Olivier Veran told BFM TV.\nMerck did not immediately respond to Reuters' request for comment.\nWhile vaccines are the main weapons against COVID-19 for governments, there are hopes Merck and Pfizer's experimental pills could be a game-changer in reducing the chances of dying or hospitalisation for those most at risk of severe illness.\nFrance had placed an early order for 50,000 doses of the drug molnupiravir developed by Merck and Ridgeback Biotherapeutics.\nThe cancellation would not incur a cost, Veran said.\nIn Italy, the office of the special commissioner for the COVID emergency said on Nov 18 it had received a mandate from the health ministry to buy 50,000 courses of Merck's pill and another 50,000 of Pfizer's one. \"The contract has not yet been finalised, but is in progress,\" a spokesperson for the commissioner told Reuters on Tuesday.\nItalian drug regulator Aifa's head Nicola Magrini told a Senate committee on Dec. 9 the two treatments could be available in Italy from the end of January.\nHowever, regardless of the availability of the drugs, there will be assessments of their use, two top government scientific advisers told Reuters.\n\"There must and will be an evaluation, independently of the assessments of regulatory bodies,\" Walter Ricciardi, top adviser of health minister Roberto Speranza, told Reuters.\nGermany has already bought Merck's antiviral treatment, health minister Karl Lauterbach told Reuters on Wednesday.\n\"This is a binding order,\" he said, adding Berlin was also in talks with Pfizer about buying its antiviral drug.\nThe European Medicines Agency is expected to decide whether to approve the Merck and Pfizer pills in the new year.\nPfizer's Paxlovid has shown near 90% efficacy in preventing COVID-19 hospitalisations and deaths in high-risk patients.\nFrance had purchased that drug instead, Veran said, without saying how many doses it had secured.\n\"France is lined up to get it before the end of January,\" Veran continued. It has not yet been decided whether the drug would be available over the counter in pharmacies, the minister said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691344912,"gmtCreate":1640141664538,"gmtModify":1640141664807,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691344912","repostId":"1196005381","repostType":4,"repost":{"id":"1196005381","pubTimestamp":1640140898,"share":"https://www.laohu8.com/m/news/1196005381?lang=&edition=full","pubTime":"2021-12-22 10:41","market":"us","language":"en","title":"GameStop Stock Set to Level Up With Adoption of Dogecoin and Shiba Inu Cryptos","url":"https://stock-news.laohu8.com/highlight/detail?id=1196005381","media":"InvestorPlace","summary":"Meme stocks and pupcoins are the peanut butter and jelly of investing — they go together so well. Th","content":"<p>Meme stocks and pupcoins are the peanut butter and jelly of investing — they go together so well. There’s no doubt that these two asset classes are colliding this year. Now, investors are seeing the assets combined in a way not seen before.<b>GameStop</b>(NYSE:<b><u>GME</u></b>), the monarch of meme stocks, is teaming up with a couple of pupcoins on payment options. GameStop stock, of course, is primed for gains from the news.</p>\n<p>The video game retailer is the genesis of a whole wave of retail stock trading, and almost nobody saw it coming. That is, nobody except for the dedicated member of Reddit’s r/WallStreetBets; these investors led a flock of buyers to GME through the year and pumped the stock’s value from $17 to a high of over $480.</p>\n<p>The success of the stock remains controversial; many institutional investors are downright certain that GME’s fundamental value is far lower than where it trades currently. Retail traders aren’t backing down.</p>\n<p>At the same time, GameStop is working very hard to mount a compelling turnaround and both satisfy skeptics and pull through for its supportive believers. Beginning with&nbsp;<b>Chewy</b>(NYSE:<b><u>CHWY</u></b>) co-founder Ryan Cohen, the company is&nbsp;adding new members&nbsp;to its board and exec team&nbsp;left and right. It is also apparently making efforts to become a play on burgeoning technologies like&nbsp;non-fungible tokens (NFTs) and Web 3.0.</p>\n<p>GameStop Stock: GME Adds Support for Shiba Inu Crypto and Dogecoin Through Flexa Partnership</p>\n<p>The company is continuing to bolster its offerings today with some exciting news for crypto traders. That’s because GameStop will be adding support for a group of crypto payments, including&nbsp;<b>Shiba Inu</b>(CCC:<b><u>SHIB-USD</u></b>) and&nbsp;<b>Dogecoin</b>(CCC:<b><u>DOGE-USD</u></b>). Investors are lauding the announcement as a big win for GameStop stock.</p>\n<p>Dogecoin and Shiba Inu are two of the most wildly popular cryptos of the year; this comes after both currencies saw massive price jumps. Now, users of the&nbsp;<b>Flexa</b>&nbsp;crypto payments app will have the opportunity to use these currencies to pay for goods at GameStop locations.</p>\n<p>The official Flexa Twitter account made the&nbsp;announcement early last week&nbsp;that GameStop will be one of the newest partners for its app. Indeed, using Flexa, users can seamlessly transact at any of its partners’ locations using crypto. Alongside DOGE and SHIB, users can pay with cryptos like&nbsp;<b>Bitcoin</b>(CCC:<b><u>BTC-USD</u></b>) and&nbsp;<b>Litecoin</b>(CCC:<b><u>LTC-USD</u></b>).</p>\n<p>This news is a big win for GameStop; indeed, many investors want places to spend their crypto holdings. And, just as many investors want opportunities to give GameStop their business. As such, this news is largely bullish for both crypto buffs and GME holders.</p>\n<p>GME is up&nbsp;0.62%&nbsp;today.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Stock Set to Level Up With Adoption of Dogecoin and Shiba Inu Cryptos</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Stock Set to Level Up With Adoption of Dogecoin and Shiba Inu Cryptos\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 10:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/gamestop-stock-set-to-level-up-with-adoption-of-dogecoin-and-shiba-inu-cryptos/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks and pupcoins are the peanut butter and jelly of investing — they go together so well. There’s no doubt that these two asset classes are colliding this year. Now, investors are seeing the ...</p>\n\n<a href=\"https://investorplace.com/2021/12/gamestop-stock-set-to-level-up-with-adoption-of-dogecoin-and-shiba-inu-cryptos/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://investorplace.com/2021/12/gamestop-stock-set-to-level-up-with-adoption-of-dogecoin-and-shiba-inu-cryptos/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196005381","content_text":"Meme stocks and pupcoins are the peanut butter and jelly of investing — they go together so well. There’s no doubt that these two asset classes are colliding this year. Now, investors are seeing the assets combined in a way not seen before.GameStop(NYSE:GME), the monarch of meme stocks, is teaming up with a couple of pupcoins on payment options. GameStop stock, of course, is primed for gains from the news.\nThe video game retailer is the genesis of a whole wave of retail stock trading, and almost nobody saw it coming. That is, nobody except for the dedicated member of Reddit’s r/WallStreetBets; these investors led a flock of buyers to GME through the year and pumped the stock’s value from $17 to a high of over $480.\nThe success of the stock remains controversial; many institutional investors are downright certain that GME’s fundamental value is far lower than where it trades currently. Retail traders aren’t backing down.\nAt the same time, GameStop is working very hard to mount a compelling turnaround and both satisfy skeptics and pull through for its supportive believers. Beginning with Chewy(NYSE:CHWY) co-founder Ryan Cohen, the company is adding new members to its board and exec team left and right. It is also apparently making efforts to become a play on burgeoning technologies like non-fungible tokens (NFTs) and Web 3.0.\nGameStop Stock: GME Adds Support for Shiba Inu Crypto and Dogecoin Through Flexa Partnership\nThe company is continuing to bolster its offerings today with some exciting news for crypto traders. That’s because GameStop will be adding support for a group of crypto payments, including Shiba Inu(CCC:SHIB-USD) and Dogecoin(CCC:DOGE-USD). Investors are lauding the announcement as a big win for GameStop stock.\nDogecoin and Shiba Inu are two of the most wildly popular cryptos of the year; this comes after both currencies saw massive price jumps. Now, users of the Flexa crypto payments app will have the opportunity to use these currencies to pay for goods at GameStop locations.\nThe official Flexa Twitter account made the announcement early last week that GameStop will be one of the newest partners for its app. Indeed, using Flexa, users can seamlessly transact at any of its partners’ locations using crypto. Alongside DOGE and SHIB, users can pay with cryptos like Bitcoin(CCC:BTC-USD) and Litecoin(CCC:LTC-USD).\nThis news is a big win for GameStop; indeed, many investors want places to spend their crypto holdings. And, just as many investors want opportunities to give GameStop their business. As such, this news is largely bullish for both crypto buffs and GME holders.\nGME is up 0.62% today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604664418,"gmtCreate":1639388851552,"gmtModify":1639393947822,"author":{"id":"3587089033625952","authorId":"3587089033625952","name":"BillyWu","avatar":"https://static.tigerbbs.com/fe9da814932e6e4dbcc103a2e82bd42f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;what happened to my darling SoFi. Down so fast but up so slow. Lol.&nbsp;","listText":"<a href=\"https://laohu8.com/S/SOFI\">$SoFi Technologies Inc.(SOFI)$</a>&nbsp;what happened to my darling SoFi. Down so fast but up so slow. Lol.&nbsp;","text":"$SoFi Technologies Inc.(SOFI)$ what happened to my darling SoFi. Down so fast but up so slow. Lol.","images":[{"img":"https://static.tigerbbs.com/d2832f797b23ee1a102aaaaac975300f","width":"1080","height":"3608"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604664418","isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}